Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
MacroGenics, Inc.
About MGNX
MacroGenics, Inc. is a biopharmaceutical company. The Company is focused on developing antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates from its proprietary suite of antibody technology platforms. It is developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which are referred to as DART and TRIDENT molecules). It has multiple proprietary product candidates. These include three clinical-stage ADCs incorporating a novel topoisomerase I inhibitor (TOP1i)-based linker-payload: MGC026, which targets B7-H3; MGC028, which targets ADAM9, and MGC030, which is directed against an undisclosed target. It is also developing lorigerlimab, a clinical-stage bispecific DART molecule targeting the immune checkpoint receptors PD-1 and CTLA-4. In addition, it is also developing multiple preclinical-stage ADC and next-generation T-cell engager programs.
Find out what a historical investment in MacroGenics, Inc. would be worth today using our MGNX stock calculator.
Market Capitalisation
$257.35M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
483
High today
$4.10
Low today
$3.89
Open price
$0.00
52-week high
$5.08
52-week low
$1.29
Ready to start your investing journey with Stake?
Open an accountHow do I buy MGNX shares in Australia?
Buying MGNX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in MacroGenics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MGNX
What is the ticker symbol of MacroGenics, Inc.?
The ticker symbol for MacroGenics, Inc. is MGNX.
How much is one share of MGNX?
One share of MGNX is valued at $4.06 as of 02 September 2026.
What is the market capitalisation of MacroGenics, Inc. MGNX?
As of 02 September 2026 MacroGenics, Inc. has a market cap of $257.35M.
What is the 52-week high for MacroGenics, Inc. stock?
The MacroGenics, Inc. 52-week high stock price is $5.08.
What is the 52-week low for MacroGenics, Inc. stock?
The MacroGenics, Inc. 52-week low stock price is $1.29.
Can I buy MGNX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MGNX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MGNX on Stake
- Buy MGNX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MGNX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MGNX related stocks